Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 12.74 CNY -7.28% Market Closed
Market Cap: 5.3B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Novogene Co Ltd stock under the Base Case scenario is 22.68 CNY. Compared to the current market price of 12.74 CNY, Novogene Co Ltd is Undervalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
22.68 CNY
Undervaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Novogene Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Novogene Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Novogene Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Novogene Co Ltd

Provide an overview of the primary business activities
of Novogene Co Ltd.

What unique competitive advantages
does Novogene Co Ltd hold over its rivals?

What risks and challenges
does Novogene Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Novogene Co Ltd.

Provide P/S
for Novogene Co Ltd.

Provide P/E
for Novogene Co Ltd.

Provide P/OCF
for Novogene Co Ltd.

Provide P/FCFE
for Novogene Co Ltd.

Provide P/B
for Novogene Co Ltd.

Provide EV/S
for Novogene Co Ltd.

Provide EV/GP
for Novogene Co Ltd.

Provide EV/EBITDA
for Novogene Co Ltd.

Provide EV/EBIT
for Novogene Co Ltd.

Provide EV/OCF
for Novogene Co Ltd.

Provide EV/FCFF
for Novogene Co Ltd.

Provide EV/IC
for Novogene Co Ltd.

Show me price targets
for Novogene Co Ltd made by professional analysts.

What are the Revenue projections
for Novogene Co Ltd?

How accurate were the past Revenue estimates
for Novogene Co Ltd?

What are the Net Income projections
for Novogene Co Ltd?

How accurate were the past Net Income estimates
for Novogene Co Ltd?

What are the EPS projections
for Novogene Co Ltd?

How accurate were the past EPS estimates
for Novogene Co Ltd?

What are the EBIT projections
for Novogene Co Ltd?

How accurate were the past EBIT estimates
for Novogene Co Ltd?

Compare the revenue forecasts
for Novogene Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Novogene Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Novogene Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Novogene Co Ltd compared to its peers.

Compare the P/E ratios
of Novogene Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Novogene Co Ltd with its peers.

Analyze the financial leverage
of Novogene Co Ltd compared to its main competitors.

Show all profitability ratios
for Novogene Co Ltd.

Provide ROE
for Novogene Co Ltd.

Provide ROA
for Novogene Co Ltd.

Provide ROIC
for Novogene Co Ltd.

Provide ROCE
for Novogene Co Ltd.

Provide Gross Margin
for Novogene Co Ltd.

Provide Operating Margin
for Novogene Co Ltd.

Provide Net Margin
for Novogene Co Ltd.

Provide FCF Margin
for Novogene Co Ltd.

Show all solvency ratios
for Novogene Co Ltd.

Provide D/E Ratio
for Novogene Co Ltd.

Provide D/A Ratio
for Novogene Co Ltd.

Provide Interest Coverage Ratio
for Novogene Co Ltd.

Provide Altman Z-Score Ratio
for Novogene Co Ltd.

Provide Quick Ratio
for Novogene Co Ltd.

Provide Current Ratio
for Novogene Co Ltd.

Provide Cash Ratio
for Novogene Co Ltd.

What is the historical Revenue growth
over the last 5 years for Novogene Co Ltd?

What is the historical Net Income growth
over the last 5 years for Novogene Co Ltd?

What is the current Free Cash Flow
of Novogene Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Novogene Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Novogene Co Ltd

Current Assets 2.5B
Cash & Short-Term Investments 1.6B
Receivables 630.7m
Other Current Assets 273.2m
Non-Current Assets 1.1B
Long-Term Investments 259.2m
PP&E 750.1m
Intangibles 46.2m
Other Non-Current Assets 19.7m
Current Liabilities 1.1B
Accounts Payable 159m
Accrued Liabilities 132.6m
Short-Term Debt 1m
Other Current Liabilities 799m
Non-Current Liabilities 45.4m
Long-Term Debt 16.8m
Other Non-Current Liabilities 28.7m
Efficiency

Earnings Waterfall
Novogene Co Ltd

Revenue
2B CNY
Cost of Revenue
-1.2B CNY
Gross Profit
860.8m CNY
Operating Expenses
-686.7m CNY
Operating Income
174.1m CNY
Other Expenses
8.8m CNY
Net Income
182.9m CNY

Free Cash Flow Analysis
Novogene Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Novogene Co Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
54/100
Profitability
Score

Novogene Co Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Novogene Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
High Altman Z-Score
Long-Term Solvency
78/100
Solvency
Score

Novogene Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Novogene Co Ltd

Wall Street analysts forecast Novogene Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Novogene Co Ltd is 19.1 CNY with a low forecast of 13.61 CNY and a high forecast of 30.45 CNY.

Lowest
Price Target
13.61 CNY
7% Upside
Average
Price Target
19.1 CNY
50% Upside
Highest
Price Target
30.45 CNY
139% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Novogene Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Novogene Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Novogene Co Ltd Logo
Novogene Co Ltd

Country

China

Industry

Life Sciences Tools & Services

Market Cap

5.3B CNY

Dividend Yield

0.37%

Description

Novogene Co., Ltd. engages in the provision of genomic services and solutions. The company is headquartered in Beijing, Beijing and currently employs 2,284 full-time employees. The company went IPO on 2021-04-13. The firm mainly relies on high-throughput sequencing technology and bioinformatics analysis technology to establish gene sequencing platforms. Combined with multi-omics research technology, the Company provides multi-level scientific and research technical services and solutions for life science basic research, medical and clinical application research. At the same time, based on the technology accumulation in gene sequencing and its application fields, the Company independently develops genetic testing medical equipment. The firm's services mainly include life science basic scientific research services, medical research and technical services, and database-building sequencing platform services. Its other services and products include gene mutation detection kits, coronavirus disease nucleic acid test service and DA8600 sequencers. The firm conducts its businesses in domestic and overseas markets.

Contact

BEIJING
Beijing
301, No. 10, Jiuxianqiao North Road, Chaoyang District
+861082837801
en.novogene.com

IPO

2021-04-13

Employees

2 284

Officers

Founder, Chairman of the Board & CEO
Dr. Ruiqiang Li
Deputy General Manager
Ms. Yanping Li

See Also

Discover More
What is the Intrinsic Value of one Novogene Co Ltd stock?

The intrinsic value of one Novogene Co Ltd stock under the Base Case scenario is 22.68 CNY.

Is Novogene Co Ltd stock undervalued or overvalued?

Compared to the current market price of 12.74 CNY, Novogene Co Ltd is Undervalued by 44%.

Back to Top